Kelly R. Thornburg
Corporate Officer/Principal at CHIMERIC THERAPEUTICS LIMITED
Profile
Kelly R.
Thornburg is currently the Vice President & Head-Quality at Chimeric Therapeutics Ltd.
(Australia) since 2022.
Previously, Thornburg worked as an Executive Director-Quality at Amgen, Inc. and as the Head-US Commercial Manufacturing at Kite Pharma, Inc. Thornburg also served as the Senior Vice President-Operations at XBiotech, Inc. from 2015 to 2017.
Thornburg obtained an undergraduate degree from Rockhurst University.
Kelly R. Thornburg active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03/02/2022 |
Former positions of Kelly R. Thornburg
| Companies | Position | End |
|---|---|---|
| XBIOTECH INC. | Chief Operating Officer | 05/05/2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Training of Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Kelly R. Thornburg
